Derudover reducerer thiazider nyreclearance af lithium og dermed øges risikoen for lithiumtoksicitet ved behandling med Irbesartan Hydrochlorothiazide BMS.
Furthermore, renal clearance of lithium is reduced by thiazides so the risk of lithium toxicity could be increased with Irbesartan Hydrochlorothiazide BMS.